Nutex Health Inc. (NASDAQ:NUTX) Short Interest Update

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 60,300 shares, an increase of 19.6% from the February 28th total of 50,400 shares. Based on an average daily volume of 39,900 shares, the short-interest ratio is currently 1.5 days. Currently, 1.9% of the company's shares are short sold.

Institutional Investors Weigh In On Nutex Health

Hedge funds have recently made changes to their positions in the stock. Topline Capital Management LLC purchased a new position in Nutex Health during the 4th quarter worth $5,690,000. American Century Companies Inc. purchased a new stake in shares of Nutex Health during the fourth quarter worth about $1,362,000. Ancora Advisors LLC acquired a new position in shares of Nutex Health during the fourth quarter valued at about $1,334,000. Drive Wealth Management LLC purchased a new position in shares of Nutex Health in the 4th quarter valued at approximately $1,122,000. Finally, Essex Investment Management Co. LLC raised its position in shares of Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after purchasing an additional 33,024 shares during the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Trading Up 5.6 %

NUTX traded up $4.02 during trading on Monday, hitting $75.39. 81,189 shares of the stock were exchanged, compared to its average volume of 52,417. Nutex Health has a 1 year low of $4.16 and a 1 year high of $77.45. The firm has a market cap of $416.76 million, a price-to-earnings ratio of -8.03 and a beta of 0.27. The firm has a 50 day simple moving average of $55.75 and a 200 day simple moving average of $38.71. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.

Wall Street Analysts Forecast Growth

Separately, Maxim Group lifted their price objective on shares of Nutex Health from $50.00 to $75.00 and gave the company a "buy" rating in a report on Thursday, February 13th.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.